Doctoral Dissertation Research: A Study of the Innovation Process

博士论文研究：创新过程研究

• 批准号: 0902784
• 负责人: David Knoke
• 金额: $ 0.32万
• 依托单位: University of Minnesota-Twin Cities
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-01 至 2010-03-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=0902784&HistoricalAwards=false
• 关键词: Doctoral; Dissertation; Research; Study; Innovation

This research extends prior work by taking a broader view of innovation in a rapidly changing and increasingly important industry: biotechnology. Scholars and practitioners assume innovation is necessary for survival as firms strive to keep pace in today's rapidly changing business climate. Although anecdotal evidence exists, current research fails to systematically answer a crucial question regarding product innovation: Should firms develop novel products or build on existing products to increase the likelihood of success at each stage of innovation (i.e., product invention, product development, product success)? To answer this question I examine data on U.S. publicly-traded biotechnology firms and their products from 1985-2005. Data collection efforts include coding company reports on product development and strategic alliances as well as coding data from patents filed with the U.S. Patent and Trademark Office. Data from patent citations allow me to evaluate the extent to which a product is central--within a network of products--relative to the firm's, alliance partner's or competitor's existing products. Analysis consists of evaluating firm, product, and alliance characteristics that are associated with success across the stages of innovation. This research provides several contributions to the understanding of biotechnology and technological innovation. First, understanding the factors that improve innovation in the biotechnology industry is critical for government and industry concerns regarding increasing costs of drugs and healthcare and for servicing the needs of an increasingly aging population in the U.S. Findings from this research should provide additional insight into factors that increase efficiency and reduce costs in biotechnology product development. Second, results from this study will yield a better understanding of the role of technology in sustaining successful innovation beyond typical alliance and resource-based explanations. Third, this study will provide a theoretical contribution to the literature on innovation more generally by conceptualizing innovation relative to both the firm and the environment across the stages of innovation.

这项研究通过更广泛地看待快速变化且日益重要的行业（生物技术）中的创新来扩展先前的工作。 学者和从业者认为，随着企业努力跟上当今快速变化的商业环境的步伐，创新对于生存是必要的。 尽管存在轶事证据，但当前的研究未能系统地回答有关产品创新的一个关键问题：企业应该开发新产品还是以现有产品为基础，以增加创新每个阶段（即产品发明、产品开发、产品成功）成功的可能性？ 为了回答这个问题，我研究了 1985 年至 2005 年美国上市生物技术公司及其产品的数据。 数据收集工作包括对公司产品开发和战略联盟报告进行编码，以及对向美国专利商标局提交的专利数据进行编码。 专利引用数据使我能够评估产品在产品网络中相对于公司、联盟伙伴或竞争对手现有产品的中心程度。 分析包括评估与创新各个阶段的成功相关的公司、产品和联盟特征。 这项研究为理解生物技术和技术创新做出了多项贡献。 首先，了解促进生物技术行业创新的因素对于政府和行业关注药品和医疗保健成本增加以及满足美国日益老龄化人口的需求至关重要。这项研究的结果应该为提高生物技术产品开发效率和降低成本的因素提供更多见解。 其次，这项研究的结果将使人们更好地理解技术在维持成功创新方面的作用，超越典型的联盟和基于资源的解释。 第三，本研究将通过概念化与创新阶段的企业和环境相关的创新，为更广泛的创新文献提供理论贡献。